Gene · 2131
Papers1,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival. | Cancers (Basel) | 2022 | 36230789 | PubTator, text mining | PubMed |
| Premalignant Conditions of Bone. | J Am Acad Orthop Surg Glob Res Rev | 2022 | 36227850 | PubTator, text mining | PubMed |
| Analysis of the Expression of Exostosins and Clinicopathological Features in Membranous Lupus Nephritis in a Chinese Cohort. | Kidney Int Rep | 2022 | 36217518 | PubTator, text mining | PubMed |
| A Symptomatic Swollen Ankle in an 8-year-old Male Child - A Rare Case Report of Dysplasia Epiphysealis Hemimelica. | J Orthop Case Rep | 2022 | 36199921 | PubTator, text mining | PubMed |
| P4HA2: A link between tumor-intrinsic hypoxia, partial EMT and collective migration. | Adv Cancer Biol Metastasis | 2022 | 36187341 | PubTator, text mining | PubMed |
| Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion. | J Biol Chem | 2022 | 36181793 | PubTator, text mining | PubMed |
| Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy. | Front Pharmacol | 2022 | 36176440 | PubTator, text mining | PubMed |
| New antigens involved in membranous nephropathy beyond phospholipase A2 receptor. | World J Nephrol | 2022 | 36161266 | PubTator, text mining | PubMed |
| Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function. | Matrix Biol Plus | 2022 | 36160687 | PubTator, text mining | PubMed |
| Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes. | Front Oncol | 2022 | 36158640 | PubTator, text mining | PubMed |
| APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases. | Mol Neurodegener | 2022 | 36153580 | PubTator, text mining | PubMed |
| Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination. | Vaccines (Basel) | 2022 | 36146521 | PubTator, text mining | PubMed |
| Local Backbone Geometry Plays a Critical Role in Determining Conformational Preferences of Amino Acid Residues in Proteins. | Biomolecules | 2022 | 36139023 | PubTator, text mining | PubMed |
| Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia. | PLoS One | 2022 | 36129940 | PubTator, text mining | PubMed |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. | Front Oncol | 2022 | 36119527 | PubTator, text mining | PubMed |
| Single-cell analysis of gene expression in the substantia nigra pars compacta of a pesticide-induced mouse model of Parkinson's disease. | Transl Neurosci | 2022 | 36117858 | PubTator, text mining | PubMed |
| The Wnt signaling cascade in the pathogenesis of osteoarthritis and related promising treatment strategies. | Front Physiol | 2022 | 36117702 | PubTator, text mining | PubMed |
| O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer. | Pathol Oncol Res | 2022 | 36110252 | PubTator, text mining | PubMed |
| The identification of a novel frameshift insertion mutation in the EXT1 gene in a Chinese family with hereditary multiple exostoses. | Clin Case Rep | 2022 | 36101782 | PubTator, text mining | PubMed |
| A glycan-based approach to cell characterization and isolation: Hematopoiesis as a paradigm. | J Exp Med | 2022 | 36066492 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2131/papers?page=17